Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist

Thorax

Volumn 52, Issue 12, 1997, Pages 1030-1035

  Reiss, Theodore F ^a   Hill, James B ^b   Harman, Eloise ^b   Zhang, Ji ^a   Tanaka, Wesley K ^a   Bronsky, Edwin ^d   Guerreiro, Debra ^a   Hendeles, Leslie ^c  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA HEALTH   (United States)

^d AAAA Medical Research Group   (United States)

Author keywords

Exercise induced bronchoconstriction; Leukotriene receptor antagonist; Montelukast

Indexed keywords

LEUKOTRIENE DERIVATIVE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; PEPTIDOLEUKOTRIENE; PLACEBO;

ADULT; ARTICLE; ASTHMA; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; EXERCISE; FORCED EXPIRATORY VOLUME; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URINARY EXCRETION;

EID: 0030696614     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.12.1030     Document Type: Article

References (23)

1. Lam S, Chan H, LeRiche JC, Chan-Yeung M, Salari H. Release of leukotrienes in patients with bronchial asthma. J Allergy Clin Immunol 1988;81:711-7.
2. 4 and histamine in asthmatics. Am Rev Respir Dis 1992;146:96-103.
3. Drazen JM, Austen KF. Leukotrienes and airway responses. Am Rev Respir Dis 1987;136:985-98.
4. Anderson SD, Daviskas E, Smith CM. Exercise-induced asthma: a difference in opinion regarding the stimulus. Allergy Proc 1989;10:215-26.
5. 4-receptor antagonist. N Engl J Med 1990;323:1736-9.
6. 4 receptor antagonist. Am Rev Respir Dis 1992;145:746-9.
7. Jarjour NN, Calhoun WJ. Exercise-induced asthma is not associated with mast cell activation or airway inflammation. J Allergy Clin Immunol 1992;89:60-8.
8. 4 in children with atopic asthma. Pediatr Res 1991;29:455-9.
9. 4-receptor antagonism in the airways of patients with asthma. Clin Pharmacol Ther 1997;61:83-92.
10. Crapo RO, Hankinson J, Irvin C, Macintyre R, Voter KZ, Wise RA. ATS standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152:1107-36.
11. Tagari P, Ethier D, Carry M, Korley V, Charleson S, Girard Y, et al. Measurement of urinary leukotrienes by reversed-phase liquid chromatography and radioimmunoassay. Clin Chem 1989;35:388-91.
12. Diamant Z, Timmers MC, van der Veen H, Friedman BS, Desmet M, Depre M, et al. The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo. J Allergy Clin Immunol 1995;42-51.
13. Muller M, Sorrel T. Quantitation of sulfidopeptide leukotrienes by high-performance liquid chromatography. J Chromatogr 1985;343:213-8.
14. Chasson AK, Grady HJ, Stanley MA. Determination of creatinine by means of automatic chemical analysis. Am J Clin Pathol 1961;35:83-8.
15. Jones B, Kenward MG. Design and analysis of cross-over trials, London: Chapman & Hall, 1990.
16. 4 levels after allergen and exercise challenge in bronchial asthma. Am Rev Respir Dis 1991; 144:1411-3.
17. 4 excretion in exercise induced asthma. J Appl Physiol 1992;73:743-8.
18. 4 after exercise challenge in children with asthma. J Allergy Clin Immunol 1992;89:1111-9.
19. 1 receptor antagonist improves asthma outcomes over a 3-month treatment period. Am J Respir Crit Care Med 1997;155: A662.
20. Anderson SD, Rodwell LT, Du Toit J, Young IH. Duration of protection by inhaled salmeterol in exercise-induced asthma. Chest 1991;100:1254-60.
21. Patel KR, Berkin KE, Kerr JW. Dose-response study of sodium cromoglycate in exercise-induced asthma. Thorax 1982;37:663-6.
22. Robuschi M, Riva E, Fuccella LM, et al. Prevention of exercise-induced bronchoconstriction by a new leukotriene antagonist (SK&F 104353). A double-blind study versus disodium cromoglycate and placebo. Am Rev Respir Dis 1992;145:1285-8.
23. Meltzer SS, Hasday JD, Cohn J, Bleecker ER. Inhibition of exercise-induced bronchospasm by zileuton: a 5-lipoxygenase inhibitor. Am J Respir Crit Care Med 1996;153: 931-5.